Jean Jacques Bienaime - 09 Sep 2021 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role: Chief Executive Officer, Director
Signature: /s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol: BMRN
Transactions as of: 09 Sep 2021
Net transactions value: -$126,893
Form type: 4
Filing time: 02 Dec 2021, 20:42:10 UTC
Previous filing: 23 Jun 2021
Next filing: 22 Oct 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BMRN	Common Stock	Small acquisition under Rule 16a-6	$3,938	+50	+0.02%	$78.77	305,889	09 Sep 2021	Direct
transaction	BMRN	Common Stock	Sale	$130,832	-1,500	-0.49%	$87.22	304,389	01 Dec 2021	Direct	F1
holding	BMRN	Common Stock						247,533	09 Sep 2021	Shares held by Jean-Jacques Bienaime Family Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 50 shares, with the reporting person's purchase of shares at a price of $78.7700 on September 9, 2021. The reporting person has agreed to pay to the Issuer the full amount of the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.

Content

The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 50 shares, with the reporting person's purchase of shares at a price of $78.7700 on September 9, 2021. The reporting person has agreed to pay to the Issuer the full amount of the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.